[1] |
Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui.
Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453.
|
[2] |
Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi.
Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459.
|
[3] |
Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde.
Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470.
|
[4] |
Hao Mingxiao, Mi Jie, Xu Zongyi.
Effectiveness of a continuity of care model in patients with tuberculous meningitis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481.
|
[5] |
Huang Misun, Wu Yaning, Li Guilian, Liu Haican.
Research advances of Mycobacterium tuberculosis enrichment technology
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 369-373.
|
[6] |
Li Qi, Wang Yujin, Wang Xueyu, Chu Naihui, Nie Wenjuan.
Study on the metabolic interaction mechanism between the novel compound WX-081 and clarithromycin
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 142-149.
|
[7] |
Zhang Chao, Yu Xia, Huang Hairong, Liu Wei, Liu Tao.
Evaluation of the in vitro antimicrobial effects of sevoflurane on Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 158-163.
|
[8] |
Liu Ruihua, Sarina , Wang Furong.
Interaction between lung cancer and tuberculosis in disease development and progression
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 102-111.
|
[9] |
Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei.
Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60.
|
[10] |
Zhao Yue, Wang Haoran, Cheng Meijin, Wang Wei, Liang Ruixia, Huang Hairong.
The evaluation of the smear-positive and Xpert-negative outcome as an early indicator of nontuberculous mycobacteria existence in clinical specimen
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 61-65.
|
[11] |
Lu Hailin, Wang Wenfei, Tao Wenhui, Lin Peicong, Chen Xinchun, Deng Guofang, Xie Shuixiang.
Oleic acid upregulates the expression of perilipin 2 enhancing macrophage clearance of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 72-76.
|
[12] |
Fan Jun, Wang Heng, Lan Tinglong, Dong Weijie, Tang Kai, Li Yuan, Yan Guangxuan, Xu Shangsheng, Kang Zhigang, Qin Shibing.
Clinical characteristics and surgical outcomes of 12 cases of non-tuberculous mycobacterial spondylitis
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 87-95.
|
[13] |
Zhong Lingshan, Wang Li, Zhang Shuo, Li Nan, Yang Qingyuan, Ding Wenlong, Chen Xingzhi, Huang Chencui, Xing Zhiheng.
A machine learning model based on CT images combined with radiomics and semantic features for diagnosis of nontuberculous mycobacterium lung disease and pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1042-1049.
|
[14] |
Wang Yilin, Wu Xiao, Pang Yu, Li Shanshan.
Immunomodulatory effect of orelabrutinib in host macrophages infected with mycobacterium
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1063-1068.
|
[15] |
Wang Fei, Hua Duo, Guo Jianjian, Liu Chang, Han Lu, Ren Yi.
Characteristic analysis of non-tuberculous mycobacterial pulmonary disease patients in Wuhan area from 2021 to 2023
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1069-1076.
|